The effect of recurrent early homograft rejection on subsequent patient and renal graft survival.
The effect of recurrent early homograft rejection on subsequent patient and renal graft survival. Two hundred renal transplants performed in Newcastle between 1968 and 1974 and followed up for at least 6 months are reviewed. There was a significant fall ingraft survival at 1 year in those patients who suffered a rejection episode during the first two months post-transplant and this fall became greater with each successive rejection episode. The rise in patient mortality with increasing numbers of rejections showed a similar trend but was less (40-50% at 1 year in those suffering 3 or 4 rejection episodes) and did not reach statistical significance beyond the first episode. We, therefore, conclude that in patients not suitable for home dialysis and in whom, because of uncommon tissue type, a second transplant is not likely to be offered under prevailing conditions of kidney donor shortage, it is justifiable to treat third and fourth rejections occurring during the first two months.
D000208:Acute Disease; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D009846:Oliguria / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy / Q000401:mortality*; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D014022:Tissue Survival / Q000187:drug effects; D014184:Transplantation, Homologous; D006113:United Kingdom
D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone